000046265 000__ 01063cam\a22003975i\4500
000046265 001__ 46265
000046265 003__ SzGeWIPO
000046265 005__ 20230511163815.0
000046265 006__ m\\\\eo\\d\\\\\\\\
000046265 007__ cr bn |||m|||a
000046265 008__ 220608s2020\\\\nyu\\\\\o\\\\\000\0\eng\d
000046265 035__ $$a(OCoLC)1335039318
000046265 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000046265 041__ $$aeng
000046265 24500 $$a"COVID-19" as a trade mark in Australia: issues and implications.
000046265 264_1 $$a[New York, NY] :$$bThomson Reuters,$$c2020
000046265 300__ $$a1 online resource
000046265 336__ $$atext$$2rdacontent
000046265 337__ $$acomputer$$2rdamedia
000046265 338__ $$aonline resource$$bcr$$2rdacarrier
000046265 4901_ $$aEuropean Intellectual Property Review,$$x0142-0461 ;$$vVolume 42, Issue 9
000046265 542__ $$fhttps://1.next.westlaw.com/Copyright
000046265 588__ $$aCrossref
000046265 590__ $$aPublished online: 2020
000046265 650_0 $$aIntellectual property.
000046265 650_4 $$aCOVID-19 pandemic
000046265 650_0 $$aTrademarks$$zAustralia.
000046265 650_0 $$aPublic health.
000046265 7001_ $$aHuang, Vicki,$$eauthor.
000046265 7731_ $$tEuropean Intellectual Property Review
000046265 7731_ $$wEIPR
000046265 830_0 $$aEuropean Intellectual Property Review,$$vE.I.P.R. 2020, 42(9), 576-583
000046265 85641 $$uhttps://www.westlaw.com/Document/I7BF6C88013F811EB8A6DF81E2F4F9E86/View/FullText.html?transitionType=Default&contextData=(sc.Default)&VR=3.0&RS=cblt1.0&sp=wlnintell-000$$yonline version
000046265 904__ $$aArticle
000046265 980__ $$aEIPR